Magnesium Sulfuricum Bbp

Magnesium sulfate heptahydrate, the active ingredient in Magnesium Sulfuricum Bbp, is a magnesium salt presented as a sterile injectable solution for intramuscular, intravenous, and subcutaneous use. It provides magnesium ions to correct magnesium deficiency and is employed in the management of conditions such as hypomagnesemia, eclampsia, and torsades de pointes in adult patients.

GNH USA supplies Magnesium Sulfuricum Bbp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics across multiple continents worldwide, with adherence to stringent quality standards.

Magnesium Sulfuricum Bbp is used to treat electrolyte disturbances and related clinical conditions where magnesium repletion is required.

- Hypomagnesemia: restores serum magnesium levels to prevent neuromuscular and cardiac complications. - Magnesium deficiency: replenishes intracellular magnesium to support enzymatic functions. - Eclampsia: provides magnesium to reduce seizure risk in pregnant patients. - Torsades de pointes: stabilizes cardiac repolarization by correcting magnesium deficit.

Adverse reactions may occur with magnesium sulfate administration.

Common Side Effects: - Injection site pain or irritation. - Flushing or warmth sensation. - Nausea or mild gastrointestinal upset. - Headache. - Dizziness or light‑headedness. - Transient hypotension.

Serious or Rare Side Effects: - Hypermagnesemia leading to respiratory depression. - Severe hypotension or cardiovascular collapse. - Cardiac arrest or severe arrhythmias. - Anaphylactic or severe allergic reactions. - Muscle weakness progressing to paralysis. - Loss of deep tendon reflexes.

Use of Magnesium Sulfuricum Bbp requires careful clinical assessment.

- Renal impairment: monitor serum magnesium and adjust dosing. - Cardiac disease: use cautiously due to potential bradycardia or conduction disturbances. - Pregnancy: evaluate risk‑benefit before administration. - Concomitant calcium therapy: avoid simultaneous IV infusion to prevent precipitation. - Drug interactions: review other magnesium‑containing products before use. - Store at ambient temperature: keep in original container, protect from moisture and light.

Magnesium sulfate may interact with several agents.

Major Interactions (Avoid): - Calcium gluconate: concurrent IV may precipitate calcium‑magnesium complexes. - Potassium‑sparing diuretics: increase risk of hypermagnesemia. - Neuromuscular blocking agents: may potentiate blockade.

Moderate Interactions (Monitor Closely): - Aminoglycoside antibiotics: may enhance nephrotoxicity. - Loop diuretics: increase renal magnesium loss, requiring close monitoring of serum levels.